Indonesian construction firm PT Brantas Abipraya is actively contributing to the national healthcare transformation by overseeing the development of the national genomic bank, Gene Bank Indonesia, located in Bogor City. The project aims to establish a crucial infrastructure for genomic data. This initiative underscores a commitment to advancing medical research and personalized healthcare within Indonesia. The genomic bank is intended to store and analyze the genetic material of the Indonesian population. Construction is reportedly proceeding as planned, ensuring the project remains on schedule. The facility is expected to play a vital role in future public health strategies and disease prevention efforts.